ProfileGDS4459 / ENSG00000205795
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 87% 87% 74% 90% 79% 79% 73% 75% 75% 75% 78% 70% 75% 85% 73% 83% 78% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.7887
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 26.6587
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.6774
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 46.9390
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.0679
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.9479
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.6773
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.7475
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.8275
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.7775
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.978
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.4470
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.6575
GSM623477group B, liver allograft wedge biopsie placebo treatment 46.4585
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.6173
GSM623479group B, liver allograft wedge biopsie placebo treatment 66.2783
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.8278